Competitive Technologies, Inc. announced today the receipt of $1.15 million from their homocysteine assay patent infringement case against Laboratory Corporation of America Holdings (LabCorp). CTT's share of the payment is approximately $230,000. The funds represent a payment against attorney's fees, court costs and post-judgment interest awarded to CTT and its clients. In June 2004 the US Court of Appeals for the Federal Circuit affirmed the CDC's November 2002 decision upholding the validity of the patent. CTT has successfully signed license agreements and is collecting royalties from companies performing the majority of homocysteine assays in the marketplace. These companies include Bayer, Abbott, Roche, Quest, Diagnostic Products and GENCHEM. CTT has an active program of collecting previously withheld royalties from all organizations involved in the homocysteine assay process. The assay patent is derived from discoveries made by CTT's clients, Drs. Robert Allen and Sally Stabler from the University of Colorado and the late Dr. John Lindenbaum from Columbia University.

Posted by GEN-ERIC at 12:05:57 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/184

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)